Abstract
Background: The effects of subclinical hyperthyroidism and clinical hyperthyroidism on bone metabolism in premenopausal women are contradictory. Methods: Sixteen hyperthyroid (31.3±9.5 yrs), 23 subclinical hyperthyroid (33.7±7.3 yrs) and 20 healthy (31.7±8.1 yrs) premenopausal women were evaluated. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry (DXA). Osteocalcin, total alkaline phosphatase (tALP), homocysteine, β-2 microglobulin, hsCRP and deoxypyridinoline (DPD) concentrations were assessed. Demographic and anthropometrical parameters; and osteoporotic risk factors were evaluated. Results: Serum calcium, tALP, osteocalcin, β-2 microglobulin and DPD were significantly different in hyperthyroid group. However there was no difference for any of the study parameters between control and subclinical hyperthyroid group. BMD was similar for all the three groups. Thyroid hormones were correlated with osteocalcin, β-2 microglobulin, tALP, lumbar vertebrae and femur BMD. Osteocalcine and tALP were significantly and negatively correlated with vertebral and femoral total BMD. Homocysteine was not different within groups but significantly correlated with tALP. Conclusions: There is limited and conflicting data about the effects of subclinical hyperthyroidism on bone turnover in premenopausal period. Despite we could not establish any difference for bone turnover markers between control group and subclinical hyperthyroid patients; with tight correlations between thyroid hormones; we can conclude that subclinical hyperthyroid patients are prone to osteoporosis even in premenopausal period.
Highlights
Adequate concentrations of thyroid hormones are necessary for bone development and maturation whereas excess concentrations enhance bone turnover and cause osteoporosis [1]
The study group was consisted of 23 subclinical hyperthyroid and 16 hyperthyroid premenopausal women while 20 healthy euthyroid premenopausal women served as the control group
ALP, osteocalcine, β-2 microglobulin and urinary DPD were significantly different in hyperthyroid group compared to both subclinical hyperthyroidism (SH) and control groups
Summary
Adequate concentrations of thyroid hormones are necessary for bone development and maturation whereas excess concentrations enhance bone turnover and cause osteoporosis [1]. This phenomenon is most obvious in patients with overt hyperthyroidism (H) some studies suggest that even mild subclinical hyperthyroidism (SH) is associated with increased bone resorption [2] and accelerated bone loss [3,4]. In suggestion to the actions of thyroid hormones, subclinical hyperthyroidism has to have similar osteoporotic effects in premenopausal period. The effects of subclinical hyperthyroidism and clinical hyperthyroidism on bone metabolism in premenopausal women are contradictory
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
